NDC 72606-0571-03
PIOGLITAZONE 30MG 500 TAB
Available — 2-Day Shipping
NDC
72606-0571-03
Generic Name
—
Brand Name
—
Strength
—
Dosage Form
—
Route
—
Package Size
—
Labeler
—
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] . Important Limitations of Use Pioglitazone tablets exert its antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be ef…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 72606-0571-03 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).